• ABASSI, Z.A., TATE, J.E., GOLOMB, E. & KEISER, H.R. (1992). Role of neutral endopeptidase in the metabolism of endothelin. Hypertension, 20, 8995.
  • ASAAD, M.M., DORSO, C.R. & MORELAND, S.M. (1993). Effects of neutral endopeptidase inhibition on the clearance of exogenously administered endothelin in Sprague-Dawley rats. J. Cardiovasc. Pharmacol., 21, 633636.
  • AUGUET, M., DELAFLOTTE, S., CHABRIER, P.-E. & BRAQUET, P. (1992). The vasoconstrictor action of big endothelin-1 is phosphoramidon-sensitive in rabbit saphenous artery but not in saphenous vein. Eur. J. Pharmacol., 114, 101102.
  • BENIGNI, A., ZOJA, C., CORNA, D., ORISIO, S., LONGARETTI, L., BERTANI, T. & REMUZZI, G. (1993). A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int., 44, 440444.
  • BROOKS, D.P., DEPALMA, P.D., PULLEN, M. & NAMBI, P. (1994). Characterization of canine renal endothelin receptor subtypes and their function. J. Pharmacol. Exp. Ther. (in press).
  • CIRINO, M., MOTZ, C., MAW, J., FORD-HUTCHINSON, A.W. & YANO, M. (1992). BQ-153, a novel endothelin (ET)A antagonist, attenuates the renal vascular effects of endothelin-1. J. Pharm. Pharmacol., 44, 782785.
  • CLOZEL, M., GRAY, G.A., BREU, V., LÖFFLER, B.-M. & OSTERWALDER, R. (1992). The endothelin ETB receptor mediates both vasodilatation and vasoconstriction in vivo. Biochem. Biophys. Res. Commun., 186, 867873.
  • CRISTOL, J.-P., WARNER, T.D., THIEMERMANN, C. & VANE, J.R. (1993). Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat. Br. J. Pharmacol., 108, 776779.
  • HOFFMAN, A., GROSSMAN, E. & KEISER, H.R. (1990). Opposite effects of endothelin-1 and Big endothelin-1(1–39) on renal function in rats. Eur. J. Pharmacol., 182, 603606.
  • KARET, F.E., KUC, R.E. & DAVENPORT, A.P. (1993). Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int., 44, 3642.
  • MIGAS, I., BÄCKER, A., MEYER-LEHNERT, J., MICHEL, H., WULFHEKEL, U. & KRAMER, H.J. (1993). Characteristics of endothelin receptors and intracellular signaling in porcine inner medullary collecting duct cells. Am. J. Hypertens., 6, 611618.
  • MINO, N., KOBAYASHI, M., NAKAJIMA, A., AMANO, H., SHIMAMOTO, K., ISHIKAWA, K., WATANABE, K., NISHIKIBE, M., YANO, M. & IKEMOTO, F. (1993). Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Eur. J. Pharmacol., 221, 7783.
  • NAMBI, P., WU, H.L., PULLEN, M., AIYAR, N., BRYAN, H. & ELLIOTT, J. (1992). Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands. Mol. Pharmacol., 42, 336339.
  • OHTA, K., NONOGUCHI, H., TOMITA, K. & MARUMO, F. (1991). Endothelin-1 inhibits AVP-stimulated osmotic water permeability in rat inner medullary collecting duct. Am. J. Physiol., 261, F951F956.
  • OPGENORTH, T.J., WU-WONG, J.R. & SHIOSAKI, K. (1992). Endothelin converting enzyme. FASEB J., 6, 26532659.
  • POLLOCK, D.M. & OPGENORTH, T.J. (1991). Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1. Am. J. Physiol., 261, R257R263.
  • POLLOCK, D.M. & OPGENORTH, T.J. (1993). Evidence for endothelin-induced renal vasoconstriction independent of ETA receptor activation. Am. J. Physiol., 264, R222R226.
  • SALVATI, P., DHO, L., CALABRESI, M., ROSA, B. & PATRONO, C. (1992). Evidence for a direct vasoconstrictor effect of big endothelin-1 in the rat kidney. Eur. J. Pharmacol., 221, 267273.
  • SLEE, S.-J., HEYS, C. & WILSON, C. (1993). Effect of BQ123 on regional hemodynamic responses to big endothelin-1 in anaesthetized rats. Br. J. Pharmacol., 108, 195P.
  • TÉLÉMAQUE, S., GRATTON, J.-P., CLAING, A. & D'ORLÉANS-JUSTE, P. (1993). Endothelin-1 induces vasoconstriction and prostacyclin release via the activation of endothelin ETA receptors in the perfused rabbit kidney. Eur. J. Pharmacol., 237, 275281.
  • TERADA, Y., TOMITA, K., NONOGUCHI, H. & MARUMO, F. (1992). Different localizations of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay. J. Clin. Invest., 90, 107112.
  • WARNER, T.D., MITCHELL, J.A., de NUCCI, G. & VANE, J.R. (1989). Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and the rabbit. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S85S88.
  • WELLINGS, R.P., WARNER, T.D., CORDER, R., THIEMERMANN, C. & VANE, J.R. (1993). A new non-selective endothelin antagonist blocks the vasoconstriction induced by endothelin in the rat. Br. J. Pharmacol., 108, 110P.
  • ZEIDEL, M.L., BRADY, H.R., KONE, B.C., GULLANS, S.R. & BRENNER, B.M. (1989). Endothelin, a peptide inhibitor of Na+-K+-ATPase in intact renal tubular epithelial cells. Am. J. Physiol., 257, C1101C1107.